Structural proteins of Kaposi's sarcoma-associated herpesvirus antagonize p53-mediated apoptosis. (Q39030014)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469037%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

title

Structural proteins of Kaposi's sarcoma-associated herpesvirus antagonize p53-mediated apoptosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469037%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469037%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Elisabeth Naschberger

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469037%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Nathalie Britzen-Laurent

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469037%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Michael Stürzl

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469037%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

P Chudasama

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469037%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

A Konrad

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469037%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

R Jochmann

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469037%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

P Holz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469037%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

F Neipel

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469037%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

language of work or name

English

0 references

publication date

27 January 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469037%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469037%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469037%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469037%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

639-649

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469037%20AND%20SRC:MED&resulttype=core&format=json

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

6 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Restricted Kaposi's sarcoma (KS) herpesvirus transcription in KS lesions from patients on successful antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Mdm2: keeping p53 under control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

p53 mutations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Cancer. p53, guardian of the genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

The p53 tumour suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Functional p53 signaling in Kaposi's sarcoma-associated herpesvirus lymphomas: implications for therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

TP53 codon 72 polymorphism in classic, endemic and epidemic Kaposi's sarcoma in African and Caucasian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Kaposi's sarcoma-associated herpesvirus open reading frame 50 represses p53-induced transcriptional activity and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 targets MDM2 to deregulate the p53 tumor suppressor pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Distinct p53, p53:LANA, and LANA complexes in Kaposi's Sarcoma--associated Herpesvirus Lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Nutlin-3 induces apoptosis, disrupts viral latency and inhibits expression of angiopoietin-2 in Kaposi sarcoma tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

In vivo activation of the p53 pathway by small-molecule antagonists of MDM2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Kaposi's sarcoma herpesvirus lytic replication compromises apoptotic response to p53 reactivation in virus-induced lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Intracellular localization map of human herpesvirus 8 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

A systems biology approach to identify the combination effects of human herpesvirus 8 genes on NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

A novel chip-based parallel transfection assay to evaluate paracrine cell interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Microarrays of cells expressing defined cDNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Characterization of gamma2-human herpesvirus-8 glycoproteins gH and gL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Kaposi's sarcoma-associated herpesvirus gH/gL: glycoprotein export and interaction with cellular receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

The ephrin receptor tyrosine kinase A2 is a cellular receptor for Kaposi's sarcoma–associated herpesvirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: maintenance of tight latency with efficient reactivation upon induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

A novel form of Epstein-Barr virus latency in normal B cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

A model for p53-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

High throughput screening of gene functions in mammalian cells using reversely transfected cell arrays: review and protocol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Inhibition of p53 tumor suppressor by viral interferon regulatory factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Subversion of autophagy by Kaposi's sarcoma-associated herpesvirus impairs oncogene-induced senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Human herpesvirus 8 glycoprotein B (gB), gH, and gL can mediate cell fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Coexpression of truncated human cytomegalovirus gH with the UL115 gene product or the truncated human fibroblast growth factor receptor results in transport of gH to the cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

HSV and glycoprotein J inhibit caspase activation and apoptosis induced by granzyme B or Fas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Bovine herpesvirus 1 glycoprotein G is required for prevention of apoptosis and efficient viral growth in rabbit kidney cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Lytic replication of Kaposi's sarcoma-associated herpesvirus results in the formation of multiple capsid species: isolation and molecular characterization of A, B, and C capsids from a gammaherpesvirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

O-GlcNAc transferase inhibits KSHV propagation and modifies replication relevant viral proteins as detected by systematic O-GlcNAcylation analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

The Rubella virus capsid is an anti-apoptotic protein that attenuates the pore-forming ability of Bax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

The West Nile virus capsid protein blocks apoptosis through a phosphatidylinositol 3-kinase-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Virion-wide protein interactions of Kaposi's sarcoma-associated herpesvirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Tegument Proteins of Kaposi's Sarcoma-Associated Herpesvirus and Related Gamma-Herpesviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Inhibition of RIG-I-mediated signaling by Kaposi's sarcoma-associated herpesvirus-encoded deubiquitinase ORF64.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Enhancement of imatinib-induced apoptosis of BCR/ABL-expressing cells by nutlin-3 through synergistic activation of the mitochondrial apoptotic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Multiple defects, including premature apoptosis, prevent Kaposi's sarcoma-associated herpesvirus replication in murine cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Inhibition of apoptosis by the gamma-herpesviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Role of neuraminidase in influenza virus-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Herpes simplex virus type 1 infection of activated cytotoxic T cells: Induction of fratricide as a mechanism of viral immune evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

NF-kappaB signaling modulation by EBV and KSHV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Early events in Kaposi's sarcoma-associated herpesvirus infection of target cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Distinct profiles of antibodies to Kaposi sarcoma-associated herpesvirus antigens in patients with Kaposi sarcoma, multicentric Castleman disease, and primary effusion lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Kaposi's sarcoma-derived cell line SLK is not of endothelial origin, but is a contaminant from a known renal carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Reverse Transfected Cell Microarrays in Infectious Disease Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Nuclear factor-kappaB motif and interferon-alpha-stimulated response element co-operate in the activation of guanylate-binding protein-1 expression by inflammatory cytokines in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

GBP-1 acts as a tumor suppressor in colorectal cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Relationship between the Quantity of Kaposi Sarcoma–Associated Herpesvirus (KSHV) in Peripheral Blood and Effusion Fluid Samples and KSHV‐Associated Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

p53 inhibition by the LANA protein of KSHV protects against cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

mdm2 expression is induced by wild type p53 activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Selective induction of TP53I3/p53-inducible gene 3 (PIG3) in myeloid leukemic cells, but not in normal cells, by Nutlin-3.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

The contribution of systems biology and reverse genetics to the understanding of Kaposi's sarcoma-associated herpesvirus pathogenesis in endothelial cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.595

Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8.

31 March 2020

1 reference

12 December 2020

Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells

1 reference

12 December 2020

Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease

1 reference

12 December 2020

Interaction of adenoviral proteins with pRB and p53.

1 reference

12 December 2020

A novel herpes simplex virus glycoprotein, gL, forms a complex with glycoprotein H (gH) and affects normal folding and surface expression of gH

1 reference

12 December 2020

Transcriptional repression of the human p53 gene by hepatitis B viral core protein (HBc) in human liver cells

1 reference

12 December 2020

Small-molecule antagonists of p53-MDM2 binding: research tools and potential therapeutics.

1 reference

12 December 2020

Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression

1 reference

12 December 2020

Transcription profile of Kaposi's sarcoma-associated herpesvirus in primary Kaposi's sarcoma lesions as determined by real-time PCR arrays

1 reference

12 December 2020

Attachment but not penetration of bovine herpesvirus 1 is necessary to induce apoptosis in target cells

1 reference

12 December 2020

Tumor suppressor p53 is a direct transcriptional activator of the human bax gene

1 reference

12 December 2020